Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

Autor: Garber, Aj, King, Ab, Del Prato, S, Sreenan, S, Balci, Mk, Muñoz Torres, M, Rosenstock, J, Endahl, La, Francisco, Am, Hollander, P, Protich, M, Ivanov, V, Veleva, N, Pichmanova, M, Guerenova, J, Hristozov, K, Slavcheva, A, Petrova, Gancheva, Prakova Teneva, Z, Böhmer, M, Clever, Hu, Kaiser, M, Peter Kempe, H, Mölle, A, Paulus, R, Rose, L, Sauter, J, Kinsley, B, Nolan, J, Hayes, F, Joshi, P, Khutsoane, Dt, Reddy, J, Mayet, L, Burgess, Lj, Raya, Pm, Cros, Mr, Calle, A, Candil, Sd, Soto, A, Francisco, J, Torres, M, Dominguez, Jr, Mesa, J, Mur, Al, Filetti, S, Piatti, P, Vespasiani, G, Santeusanio, F, Fanelli, Carmine Giuseppe, Mannucci, E, Consoli, A, Pata, P, Cignarelli, M, Borzì, V, Trevisan, R, Serban, V, Catrinoiu, D, Creteanu, G, Pop, L, Coman, A, Dogadin, S, Dvoryashina, I, Karpova, I, Lysenko, T, Smirnova, E, Yakusevich, V, Fábry, J, Ilavská, A, Tomášová, L, Tošerová, E, Chow, Fc, Karsidag, K, Erguney, M, Akbay, E, Balçi, Mk, Anderson, C, Baker, C, Berbano, R, Blevins, T, Broadstone, V, Brody, M, Brunner, J, Brusco, O, Case, C, Cherlin, R, Chuck, L, Clower, J, Connor, G, Cooperman, M, Paysinger, A, Early, M, Elliott, S, Fitz Patrick, D, Furlong, K, Garber, A, Glaser, L, Albert, S, Griffing, G, Handke, L, Harris, R, Hermayer, K, Huntley, R, Kaye, W, Kennedy, J, King, A, Klein, E, Lipetz, R, Snell, P, Morawski, E, Nurnberg, R, Orr, R, Osei, K, Palace, E, Raad, G, Rasmussen, B, Reeves, M, Roberts, V, Rodbard, H, Rosenblit, P, Selam, Jl, Shaw, S, Shelmet, J, Simon, H, Smith, M, Stringam, S, Sussman, A, Testa, J, Mazza, A, Varano, S, Warren, M, Winkle, P, Wise, J, Aroda, V, Strzinek, R, Wong, M, Pollock, J, Bode, B.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3982::2ad6aa94253a2f2a8b3e1642b79e9116
http://hdl.handle.net/11391/912344

Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 Trial.

Autor: Bowering K; Division of Endocrinology and Metabolism, University of Alberta, Edmonton, Alberta, Canada keith.bowering@ualberta.ca., Case C; Jefferson City Medical Group, Jefferson City, MO., Harvey J; Gladstone Centre, Maelor Hospital, Bangor University, Wrexham, U.K., Reeves M; Diabetes Clinical Trials, Chattanooga, TN., Sampson M; Diabetes, Endocrinology and General Medicine, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, U.K., Strzinek R; Protenium Clinical Research, Hurst, TX., Bretler DM; Novo Nordisk A/S, Søborg, Denmark., Bang RB; Novo Nordisk A/S, Søborg, Denmark., Bode BW; Atlanta Diabetes Associates, Atlanta, GA.

Publikováno v: Diabetes care [Diabetes Care] 2017 Jul; Vol. 40 (7), pp. 951-957. Date of Electronic Publication: 2017 May 08.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Investigation of Severe Hypoglycemia Risk Among Patients with Diabetes Treated with Ultra-Rapid Lispro in Japan.

Autor: Mizuno S; Eli Lilly Japan K.K., 5-1-28 Isogami-dori, Chuo-ku, Kobe, 651-0086, Japan. mizuno_seiko@lilly.com., Minatoya M; Eli Lilly Japan K.K., 5-1-28 Isogami-dori, Chuo-ku, Kobe, 651-0086, Japan., Osaga S; Eli Lilly Japan K.K., 5-1-28 Isogami-dori, Chuo-ku, Kobe, 651-0086, Japan., Chin R; Eli Lilly Japan K.K., 5-1-28 Isogami-dori, Chuo-ku, Kobe, 651-0086, Japan., Imori M; Eli Lilly Japan K.K., 5-1-28 Isogami-dori, Chuo-ku, Kobe, 651-0086, Japan.

Publikováno v: Advances in therapy [Adv Ther] 2024 Nov 21. Date of Electronic Publication: 2024 Nov 21.

Insulin Tregopil: An Ultra-Fast Oral Recombinant Human Insulin Analog: Preclinical and Clinical Development in Diabetes Mellitus.

Autor: Joshi, Shashank, Jayanth, Vathsala, Loganathan, Subramanian, Sambandamurthy, Vasan K., Athalye, Sandeep N.

Publikováno v: Drugs; Sep2023, Vol. 83 Issue 13, p1161-1178, 18p